Search Results 11-20 of 9488 for TNF

  1. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    ... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...

  2. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    ... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...

  3. Mayo Clinic Q and A: With psoriatic arthritis, the sooner therapy is started, the better

    Immunosuppressants — These medications act to tame your immune system, which is out of control in psoriatic arthritis. Tumor necrosis factor-alpha (TNF-alpha) ...

  4. Weekend Wellness: Ankylosing spondylitis symptom changes hard to predict

    TNF stands for tumor necrosis factor — a cell protein that leads to inflammation. TNF blockers target this protein to help reduce pain, stiffness, and ...

  5. Adrian T. Ting, Ph.D. - Mayo Clinic Faculty Profiles

    Ting's lab studies primarily post-translational mechanisms that dictate cell survival versus death in response to tumor necrosis factor (TNF). Even though TNF ...

  6. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    Have had anti-tumor necrosis factor (TNF)-alpha therapy and were unresponsive by 1 of the following 2 reasons: Lack of benefit to at least 1 anti-TNF-alpha ...

  7. A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor - Mayo Clinic

    A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor.

  8. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

  9. Sacroiliitis - Diagnosis and treatment - Mayo Clinic

    Interleukin-17 (IL-17) inhibitors include secukinumab (Cosentyx) and ixekizumab (Taltz). Tumor necrosis factor (TNF) inhibitors include etanercept (Enbrel), ...

  10. Ankylosing spondylitis - Diagnosis & treatment - Mayo Clinic

    If nonsteroidal anti-inflammatory drugs (NSAIDs) aren't helpful, your doctor might suggest starting a tumor necrosis factor (TNF) blocker or an interleukin-17 ( ...